News & Events

News & Events

Date Title Format
Oct 08, 2019 Cyclerion Therapeutics and Collaborators to Present New Research on the Sickle Cell Disease Patient Journey at Upcoming Medical Meetings
Sep 10, 2019 Cyclerion to Host Webcast Investor Event on Cardiometabolic Programs on September 17
Aug 12, 2019 Cyclerion Therapeutics Reports Second Quarter 2019 Financial Results and Progress on Four Clinical Studies with Data Readouts Anticipated in the Next 12 Months
Jun 11, 2019 Cyclerion Therapeutics to Present Preclinical Data on its Clinical-Stage sGC Stimulators for Neurodegenerative and Cardiometabolic Diseases at the 9th International Conference on cGMP
Jun 04, 2019 Cyclerion Therapeutics to Present Data on its Sickle Cell Disease Program at Upcoming Medical and Scientific Meetings
May 13, 2019 Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company
Apr 25, 2019 Cyclerion to Host Corporate Overview Call on May 13, 2019
Apr 09, 2019 Cyclerion Announces the Appointment of Andreas Busch, Ph.D., as Chief Innovation Officer
Apr 02, 2019 Cyclerion Launches as Clinical-Stage Biopharmaceutical Company Harnessing the Power of Soluble Guanylate Cyclase (sGC) Pharmacology for Treatment of Serious and Orphan Diseases
Feb 26, 2019 Cyclerion, the Planned R&D Spin-off of Ironwood Pharmaceuticals, Secures Commitments of $175 Million in Private Offering
Top